#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Becker's muscular dystrophy Extraskeletal ossification Mitochondrial myopathy Aicardi-Goutieres syndrome Choroidal dystrophy Non-small cell lung cancer metastatic Anaplastic large cell lymphoma T- and null-cell types Pyoderma gangrenosum C3 glomerulopathy Myeloproliferative neoplasm Peripheral T-cell lymphoma unspecified Cutaneous T-cell lymphoma recurrent Cystic fibrosis gastrointestinal disease Hypomagnesaemia Ovarian epithelial cancer More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Basic Information Methylmalonic acidaemia – Treatment Metachromatic leukodystrophy – Diagnostics Behcet’s syndrome – Life with Disease Aicardi-Goutieres syndrome – Treatment Marginal zone lymphoma – Basic Information Testicular leiomyosarcoma – Basic Information Primary hyperoxaluria – Basic Information Shprintzen-Goldberg syndrome – Diagnostics Systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Follitropin Beta Acetylcholine Chloride Lisocabtagene Maraleucel TX000045 Romosozumab Atidarsagene Autotemcel Venlafaxine Hydrochloride Gsk3915393 Macrogol 3350 Kk8123 Fenfluramine Hydrochloride Rusfertide Amifostine Thiol Fluciclovine (18F) Esflurbiprofen Quinapril Hydrochloride Imifoplatin ATOVAQUONE GSK4524101A Gns561 More therapies…

    Learn about Your Condition

    Pyoderma gangrenosum Testis cancer Abortion threatened Endometrial cancer stage III Osteogenesis imperfecta Viral infection Encephalopathy neonatal Spinal cord injury cervical Acromegaly Cardiac failure congestive Colorectal cancer stage II Multiple sclerosis Perinatal depression Oral lichen planus Inflammatory bowel disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Evaluating 68Ga-FAPI-46 PET/CT Scanning for Improved Diagnosis in Patients with Pancreatic Cancer or Bile Duct Cancer Eligible for Curative Treatment

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Gallium (68Ga) Chloride
    • Germanium (68Ge) Chloride
    France

  • Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypochondroplasia
    Investigated Drugs:
    • Infigratinib
    • Placebo
    France Norway Portugal Spain Sweden

  • Clinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +2

  • Study on BCG Vaccine and Rabies Virus (Inactivated) for Healthy Volunteers: Exploring Pre-Vaccination Immune Status and Its Impact on Vaccine Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mycobacterium Bovis, Danish Strain 1331
    The Netherlands

  • Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Sepiapterin
    France Ireland Poland Sweden

  • Study on the Effectiveness of Abatacept for Patients with Giant Cell Arteritis

    Recruiting

    3 1
    Investigated Drugs:
    • Abatacept
    Germany Italy
Previous Page
1 … 172 173 174 175 176 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!